4KAI image
Deposition Date 2013-04-22
Release Date 2013-05-08
Last Version Date 2024-03-13
Entry Detail
PDB ID:
4KAI
Title:
HCV NS5B GT1B N316 with GSK5852A
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.24
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HCV Polymerase
Mutations:L47Q,F101Y,K114R
Chain IDs:A, B
Chain Length:577
Number of Molecules:2
Biological Source:Hepatitis C virus
Ligand Molecules
Primary Citation

Abstact

A boronic acid moiety was found to be a critical pharmacophore for enhanced in vitro potency against wild-type hepatitis C replicons and known clinical polymorphic and resistant HCV mutant replicons. The synthesis, optimization, and structure-activity relationships associated with inhibition of HCV replication in a subgenomic replication system for a series of non-nucleoside boron-containing HCV RNA-dependent RNA polymerase (NS5B) inhibitors are described. A summary of the discovery of 3 (GSK5852), a molecule which entered clinical trials in subjects infected with HCV in 2011, is included.

Legend

Protein

Chemical

Disease

Primary Citation of related structures